Vody Vincent
Psychiatric/Mental Health · Union, NJNPI 1013059575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 266 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Alkermes, Inc. at 24.4% of the total. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 266 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$788
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$689
- Johnson & Johnson$633
- AbbVie$610
- Lundbeck LLC$313
- plus $840 from 9 others
What the payments were for
- Food & beverage$5,125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 60 | $1,252 |
| Teva Pharmaceuticals USA, Inc. | 52 | $788 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $689 |
| Johnson & Johnson | 24 | $633 |
| AbbVie | 31 | $610 |
| Lundbeck LLC | 19 | $313 |
| Vanda Pharmaceuticals Inc. | 16 | $227 |
| Supernus Pharmaceuticals, Inc. | 5 | $183 |
| Otsuka America Pharmaceutical, Inc. | 9 | $143 |
| Neurocrine Biosciences, Inc. | 7 | $118 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Ironshore Pharmaceuticals Inc. | 3 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $34 |
| Tris Pharma Inc | 1 | $15 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$968
- INVEGA SUSTENNA$268
- INVEGA TRINZA$144
- CAPLYTA$125
- QELBREE$125
- VRAYLAR$108
How this compares
$5,125 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 75 | $11,275 |
| Quetiapine Fumarate | 124 | $1,922 |
| Divalproex Sodium | 35 | $509 |
| Mirtazapine | 63 | $438 |
| Risperidone | 45 | $358 |
| Bupropion XlBupropion Hcl | 20 | $235 |
| Paroxetine Hcl | 11 | $223 |
| Buspirone Hcl | 23 | $217 |
| Duloxetine Hcl | 20 | $216 |
| Lamotrigine | 40 | $214 |
| Olanzapine | 11 | $149 |
| Trazodone Hcl | 51 | $143 |
| Escitalopram Oxalate | 30 | $115 |
| Sertraline Hcl | 59 | $107 |
| Benztropine Mesylate | 13 | $99 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Union
- Kevin ObiUnion$11K
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.